Source: immuno-oncologynews.com Author: Daniela Semedo, PhD University of Cincinnati scientists have recently discovered that DEK, a human gene known to cause cancer, can be detected in the plasma of patients with head and neck cancer. DEK may help clinicians understand how a person's immune system can be used to treat cancer or predict outcomes for […]
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://ift.tt/1Y2FxXZ
via IFTTT
from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1RIcR48
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου